Literature DB >> 21621533

Ephexin4 and EphA2 mediate resistance to anoikis through RhoG and phosphatidylinositol 3-kinase.

Kohei Harada1, Nao Hiramoto-Yamaki, Manabu Negishi, Hironori Katoh.   

Abstract

Disruption of cell-extracellular matrix interaction causes epithelial cells to undergo apoptosis called anoikis, and resistance to anoikis has been suggested to be a critical step for cancer cells to metastasize. EphA2 is frequently overexpressed in a variety of human cancers, and recent studies have found that overexpression of EphA2 contributes to malignant cellular behavior, including resistance to anoikis, in several different types of cancer cells. Here we show that Ephexin4, a guanine nucleotide exchange factor for the small GTPase RhoG that interacts with EphA2, plays an important role in the regulation of anoikis. Knockdown of Ephexin4 promoted anoikis in HeLa cells, and experiments using a knockdown-rescue approach showed that activation of RhoG, phosphatidylinositol 3-kinase (PI3K), and Akt was required for the Ephexin4-mediated suppression of anoikis. Indeed, Ephexin4 knockdown caused a decrease in RhoG activity and Akt phosphorylation in HeLa cells cultured in suspension. In addition, Ephexin4 was involved in the EphA2-mediated suppression of anoikis. Taken together, these results suggest that Ephexin4 mediates resistance to anoikis through activation of RhoG and PI3K downstream of EphA2.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21621533     DOI: 10.1016/j.yexcr.2011.05.014

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  21 in total

1.  miR-124-regulated RhoG reduces neuronal process complexity via ELMO/Dock180/Rac1 and Cdc42 signalling.

Authors:  Kristin Franke; Wolfgang Otto; Sascha Johannes; Jan Baumgart; Robert Nitsch; Stefan Schumacher
Journal:  EMBO J       Date:  2012-05-15       Impact factor: 11.598

Review 2.  Eph receptor signaling and ephrins.

Authors:  Erika M Lisabeth; Giulia Falivelli; Elena B Pasquale
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 3.  EphA receptor signaling--complexity and emerging themes.

Authors:  Hui Miao; Bingcheng Wang
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

Review 4.  Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression.

Authors:  Cassandra L Buchheit; Kelsey J Weigel; Zachary T Schafer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

Review 5.  RhoGEFs in cell motility: novel links between Rgnef and focal adhesion kinase.

Authors:  N L G Miller; E G Kleinschmidt; D D Schlaepfer
Journal:  Curr Mol Med       Date:  2014-02       Impact factor: 2.222

6.  Emerging role of ILK and ELMO2 in the integration of adhesion and migration pathways.

Authors:  Ernest Ho; Lina Dagnino
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

7.  Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.

Authors:  Narayana Yeddula; Yifeng Xia; Eugene Ke; Joep Beumer; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-05       Impact factor: 11.205

8.  Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner.

Authors:  Amar B Singh; Ashok Sharma; Punita Dhawan
Journal:  Carcinogenesis       Date:  2012-08-31       Impact factor: 4.944

9.  Protein kinase C phosphorylates the EphA2 receptor on serine 892 in the regulatory linker connecting the kinase and SAM domains.

Authors:  Marina P Gehring; Elena B Pasquale
Journal:  Cell Signal       Date:  2020-05-13       Impact factor: 4.315

10.  Ephexin4-mediated promotion of cell migration and anoikis resistance is regulated by serine 897 phosphorylation of EphA2.

Authors:  Hiromu Kawai; Masakazu Kobayashi; Nao Hiramoto-Yamaki; Kohei Harada; Manabu Negishi; Hironori Katoh
Journal:  FEBS Open Bio       Date:  2013-01-21       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.